Hims & Hers Health Income After Taxes 2020-2024 | HIMS
Hims & Hers Health annual/quarterly income after taxes history and growth rate from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Hims & Hers Health income after taxes for the quarter ending June 30, 2024 was $0.013B, a 285.79% decline year-over-year.
- Hims & Hers Health income after taxes for the twelve months ending June 30, 2024 was $0.018B, a 138.54% decline year-over-year.
- Hims & Hers Health annual income after taxes for 2023 was $-0.024B, a 64.15% decline from 2022.
- Hims & Hers Health annual income after taxes for 2022 was $-0.066B, a 38.99% decline from 2021.
- Hims & Hers Health annual income after taxes for 2021 was $-0.108B, a 494.34% increase from 2020.
| Hims & Hers Health Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $-24 |
| 2022 | $-66 |
| 2021 | $-108 |
| 2020 | $-18 |
| 2019 | $-72 |
| 2018 | $ |
| Hims & Hers Health Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-06-30 | $13 |
| 2024-03-31 | $11 |
| 2023-12-31 | $1 |
| 2023-09-30 | $-8 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-11 |
| 2022-09-30 | $-19 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-31 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-9 |
| 2021-03-31 | $-51 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-6 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.988B | $0.872B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |